股票简称：巨化股份 股票代码：600160 公告编号：临 2024－33 浙江巨化股份有限公司 2、同比：指报告期与上年同期相比； 3、外销量低于产量，主要为部分产品作为内部下游产品原料所致； 4、基础化工产品中不含乙炔气、氢气、香精、冷冻油及其他非主要产品（下同）； 2024 年 1-9 月主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）根据《上海证券交易所上市公司 自律监管指引第 3 号——行业信息披露（第十三号化工）》有关规定，将公司 2024 年 1-9 月主要经营数据披露如下： | 主要产品 | 产量 | 同比 | 外销量 | 同比 | 营业收入 | 同比 | | --- | --- | --- | --- | --- | --- | --- | | | 吨 | % | 吨 | % | 万元 | % | | 氟化工原料 | 834593.50 | 5.02 | 263526.58 | -0.26 | 89882.13 | 15.10 | | 致冷剂 | ...

股票代码：600160 股票简称：巨化股份 公告编号：2024-34 浙江巨化股份有限公司 关于召开 2024 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2024 年 11 月 12 日(星期二) 下午 15:00-16:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2024 年 11 月 05 日(星期二) 至 11 月 11 日(星期一)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 jhgf@juhua.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 浙江巨化股份有限公司（以下简称"公司"）已于 2024 年 10 月 24 日发布公 司 2024 年第三季度报告，为便于广大投资者更全面深入地了解公司 2024 年度第 三季度经营成果、财务状况，公司计划于 2024 年 11 月 12 日 ...

Financial Performance - Operating revenue for Q3 2024 was CNY 5,826,285,665.56, a decrease of 1.53% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 reached CNY 423,347,050.92, an increase of 64.76% year-on-year[2] - Net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was CNY 390,449,718.16, up 67.81% from the previous year[2] - Basic earnings per share for Q3 2024 was CNY 0.157, reflecting a growth of 65.26% compared to the same period last year[3] - Total operating revenue for the first three quarters of 2024 reached ¥17.91 billion, an increase of 11.8% compared to ¥16.01 billion in the same period of 2023[15] - Net profit for the first three quarters of 2024 was ¥1.39 billion, a significant increase of 83.4% compared to ¥757.70 million in 2023[16] - Earnings per share for the first three quarters of 2024 were ¥0.466, compared to ¥0.277 in the same period last year, reflecting a 68.3% increase[18] - The company reported a total comprehensive income of ¥1.39 billion for the first three quarters of 2024, compared to ¥755.90 million in 2023, marking an increase of 84.1%[18] Assets and Liabilities - Total assets as of the end of Q3 2024 amounted to CNY 27,770,524,486.44, an increase of 18.76% from the end of the previous year[3] - As of September 30, 2024, the total assets of Zhejiang Juhua Co., Ltd. reached approximately CNY 27.77 billion, an increase from CNY 23.38 billion at the end of 2023, representing a growth of about 18.5%[11] - The company's current assets totaled approximately CNY 8.20 billion, up from CNY 6.42 billion, indicating a growth of around 27.8%[12] - The total liabilities of the company reached approximately CNY 9.41 billion, up from CNY 7.01 billion, indicating an increase of about 34.3%[13] - The company's equity remained stable at approximately CNY 2.70 billion, unchanged from the previous period[13] - The total equity attributable to shareholders of the parent company increased to ¥17.06 billion, up from ¥16.07 billion in the previous year, reflecting a growth of 6.1%[14] Cash Flow - The company reported a net cash flow from operating activities of CNY 799,954,233.84 for the year-to-date, representing a growth of 13.79%[3] - The net cash flow from operating activities for the third quarter was ¥799,954,233.84, an increase from ¥703,018,100.02 in the same period last year, representing a growth of approximately 13.8%[20] - Total cash inflow from operating activities amounted to ¥19,956,152,746.50, compared to ¥18,561,973,841.25 in the previous year, indicating an increase of about 7.5%[20] - Cash outflow for purchasing goods and services was ¥16,782,867,845.54, up from ¥15,279,250,406.60, reflecting a rise of approximately 9.8%[20] - The net cash flow from investing activities was -¥1,892,283,957.48, worsening from -¥845,341,871.19 year-over-year[21] - Cash inflow from financing activities totaled ¥2,711,005,172.24, significantly higher than ¥553,790,811.05 in the previous year, marking an increase of about 389.5%[21] - The net cash flow from financing activities was ¥537,774,102.82, compared to -¥392,950,534.67 in the same quarter last year, indicating a positive turnaround[21] Operational Highlights - The increase in net profit is primarily attributed to rising prices and sales volume of refrigerant products[6] - The company completed the acquisition of Zibo Feiyuan Chemical Co., Ltd. in January 2024, integrating it into the financial statements[10] - The production of the third-generation fluorinated refrigerants (HFCs) commenced in January 2024, in accordance with national production quotas[10] - Research and development expenses for the first three quarters of 2024 were ¥849.42 million, up 15.0% from ¥738.56 million in 2023, indicating a focus on innovation[16] Inventory and Receivables - The inventory value increased significantly to approximately CNY 2.64 billion from CNY 1.76 billion, reflecting a rise of about 49.4%[12] - Accounts receivable rose to approximately CNY 1.61 billion, compared to CNY 920.56 million, marking an increase of about 74.9%[11] - The company's short-term borrowings surged to approximately CNY 1.28 billion from CNY 605.05 million, an increase of about 111.1%[13] - Long-term borrowings also increased to approximately CNY 2.63 billion from CNY 1.74 billion, representing a growth of about 51.1%[13] Dividend and Interest Payments - The cash paid for dividends and interest was ¥413,193,331.08, down from ¥758,680,207.00, reflecting a decrease of about 45.5%[21]

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [4]. Core Views - The company is a leading player in the fluorochemical industry, benefiting from a complete industrial chain and a favorable market environment for refrigerants [14][17]. - The supply of refrigerants is expected to remain tight due to policy constraints, which will enhance profitability for the company [26][27]. - The company is well-positioned to capitalize on the high profitability of refrigerants, particularly as it holds a significant share of production quotas for both second and third-generation refrigerants [5][20]. Summary by Sections Company Overview - The company is a domestic leader in fluorochemical production, with a highly integrated operational model that includes chlor-alkali, sulfuric acid, coal chemical, and basic fluorochemical industries [14][16]. - It has established a complete fluorochemical industrial chain, including basic raw materials, fluorinated refrigerants, organic fluorine monomers, fluorinated polymers, and fine chemicals [14][16]. Refrigerants - The supply side of fluorinated refrigerants is constrained by policies, which is expected to maintain a tight market [26]. - The production quotas for second-generation refrigerants, particularly R22, are being reduced significantly, which is anticipated to enhance profitability [20][27]. - The third-generation refrigerants are expected to see improved profitability in 2024 due to policy enforcement and strong demand from the air conditioning sector [20][26]. Fluoropolymers - The company has a diverse range of fluoropolymer materials, with a focus on high-end applications [5][19]. - It is investing in high-performance fluoropolymer research and development, including projects aimed at the semiconductor industry [5][19]. Financial Forecast - The company is projected to achieve net profits of 2.345 billion, 3.386 billion, and 4.333 billion yuan for the years 2024, 2025, and 2026, respectively [6]. - Revenue is expected to grow from 20.655 billion yuan in 2023 to 32.556 billion yuan in 2026, reflecting a compound annual growth rate [6]. Investment Recommendation - The company is positioned to benefit from the high profitability of refrigerants and the growth of its fluoropolymer business, with a favorable outlook for the next few years [5][20].

C o m p a n y U p d a t e 公司基本资讯 产业别 化工 A 股价(2024/9/19) 16.58 上证指数(2024/9/19) 2736.02 股价 12 个月高/低 25.98/13.74 总发行股数(百万) 2699.75 A 股数(百万) 2699.75 A 市值(亿元) 447.62 主要股东 巨化集团有限 公司(52.70%) 每股净值(元) 6.17 股价/账面净值 2.69 一个月 三个月 一年 股价涨跌(%) -4.9 -31.3 7.5 近期评等 出刊日期 前日收盘 评等 2024.1.30 15.89 区间操作 2024.03.15 19.21 买进 产品组合 制冷剂 35.4% 其他 19.0% 石化材料 16.5% 基础化工产品及 其它 14.6% 机构投资者占流通 A 股比例 基金 0.8% 一般法人 60.3% 2024 年 09 月 20 日 费倩然 H70507@capital.com.tw 目标价(元) 22 C h i n a R e s e a r c h D e p t . 巨化股份(600160.SH) Buy 买进 二代份额削减，看好制冷 ...

股票简称：巨化股份 股票代码：600160 公告编号：临 2024-32 浙江巨化股份有限公司关于担保进展情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 被担保人名称 浙江巨化股份有限公司（以下简称"公司"或"本公司"）之全资子公司宁波巨 化化工科技有限公司（以下简称"宁波化工公司"）；巨化贸易（香港）有限公司 （以下简称"香港贸易公司"）；控股子公司浙江晋巨化工有限公司（以下简称"晋 巨公司"）。 担保金额及已实际为其提供的担保余额 本次新增为晋巨公司、香港贸易公司、宁波化工公司融资提供担保，合计担 保金额人民币 13,380.16 万元。其中新增为晋巨公司一笔融资提供担保，合计金 额人民币 2,224.26 万元；新增为香港贸易公司一笔融资提供担保，合计担保金 额 1,155 万美元，折合成人民币 8,214.82 万元；新增为宁波化工公司两笔融资 提供担保 301 万欧元及 80 万美元，折合成人民币共 2,941.08 万元。（美元汇率 按中国人民银行官网 8 月 30 日中间价 7. ...

-基础化工 | 证券研究报告 — 调整盈利预测 2024 年 9 月 18 日 600160.SH 买入 原评级：买入 市场价格:人民币 15.96 板块评级:强于大市 本报告要点 24H1 公司业绩大幅增长，看好制冷剂行 业景气度提升、公司氟化工产业布局优 化带来的业绩增长，维持买入评级。 股价表现 (%) 今年 至今 1 个月 3 个月 12 个月 (14%) 2% 18% 33% 49% 65% Sep-23Oct-23Nov-23Dec-23Jan-24Feb-24Mar-24Apr-24May-24Jul-24Aug-24Sep-24 巨化股份 上证综指 绝对 (1.5) (13.4) (30.0) 0.7 相对上证综指 7.2 (7.7) (19.2) 14.1 | --- | --- | |----------------------------------------|-----------| | | | | | | | 发行股数 ( 百万 ) | 2,699.75 | | 流通股 ( 百万 ) | 2,699.75 | | 总市值 ( 人民币 百万 ) | 43,087.95 | | 3 个 ...

证券代码：600160 证券简称：巨化股份 公告编号：临 2024-31 浙江巨化股份有限公司 2024 年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 509 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 1,590,100,613 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 58.8981 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 1、 议案名称：《关于聘任会计师事务所的议案》 本次会议由公司董事会召集，采用现场投票和网络投票相结合的方式召开， 符合《公司法》和《公司章程》及相关法律、法规的规定，会议的召开及议案表 决合法有效。经公司半数以上董事推举，现场会议由公司董事、董事会秘书刘云 1 (一) 股东大会召开的时间：2024 年 9 月 12 日 (二) ...

国浩律师（杭州）事务所 法律意见书 国浩律师（杭州）事务所 关于 浙江巨化股份有限公司 2024 年第一次临时股东大会之 法律意见书 致：浙江巨化股份有限公司 国浩律师（杭州）事务所（以下简称"本所"）接受浙江巨化股份有限公司 （以下简称"公司"）的委托，指派律师出席公司 2024 年第一次临时股东大会 （以下简称"本次股东大会"），并根据《中华人民共和国公司法》（以下简称 "《公司法》"）、《中华人民共和国证券法》、中国证券监督管理委员会（以 下简称"中国证监会"）发布的《上市公司股东大会规则》（以下简称"《股东 大会规则》"）、《上市公司治理准则》（以下简称"《治理准则》"）和上海 证券交易所发布的《上海证券交易所上市公司自律监管指引第 1 号——规范运 作》（以下简称"《规范运作指引》"）等法律、行政法规、规范性文件及现行 有效的《浙江巨化股份有限公司章程》（以下简称"《公司章程》"）、《浙江 巨化股份有限公司股东大会议事规则》（以下简称"《股东大会议事规则》"） 的规定，就本次股东大会的召集、召开程序、出席大会人员资格、会议表决程序 等事宜出具法律意见书。 为出具本法律意见书，本所律师列席了公司本次股 ...

[Table_Summary] [Table_Title] 制冷剂盈利能力改善，看好行业长期竞争格局 [Table_ReportDate] 巨化股份(600160)公司简评报告 | 2024.09.11 [Table_Rank] 评级： 买入 核心观点 [Table_Authors] 翟绪丽 首席分析师 SAC 执证编号：S0110522010001 zhaixuli@sczq.com.cn 电话：010-81152683 [Table_Chart] 市场指数走势（最近 1 年） -0.5 0 0.5 1 巨化股份 沪深300 11-Sep 23-Nov 4-Feb17-Apr 29-Jun 10-Sep 资料来源：聚源数据 | --- | --- | |---------------------------------|-------------| | [Table_BaseData] 公司基本数据 | | | 最新收盘价（元） | 15.01 | | 一年内最高 / 最低价（元） | 25.99/13.69 | | 市盈率（当前） | 31.46 | | 市净率（当前） | 2.43 | | 总股本（亿股 ...